TABLE 2.
Characteristics |
Univariate |
Multivariate |
||||
HR | 95% CI | p-value | HR | 95% CI | p-value | |
Age, years | 0.818 | 0.530–1.263 | 0.365 | 0.741 | 0.478–1.150 | 0.181 |
Histologic type | ||||||
AD/ASC | 1.00 (ref.) | 1.00 (ref.) | ||||
SCC | 1.256 | 0.706–2.234 | 0.438 | 1.301 | 0.709–2.387 | 0.395 |
FIGO stage | ||||||
I–II | 1.00 (ref.) | 1.00 (ref.) | ||||
III–IV | 2.490 | 1.588–3.905 | <0.001 | 1.782 | 1.060–2.995 | 0.029 |
Histologic grade | ||||||
G1-G2 | 1.00 (ref.) | 1.00 (ref.) | ||||
G3 | 1.575 | 1.018–2.436 | 0.041 | 1.313 | 0.835–2.064 | 0.239 |
Lymph node metastasis | ||||||
No | 1.00 (ref.) | 1.00 (ref.) | ||||
Yes | 3.341 | 2.115–5.276 | <0.001 | 1.887 | 1.083–3.287 | 0.025 |
Snail expression | ||||||
Low | 1.00 (ref.) | 1.00 (ref.) | ||||
High | 2.238 | 1.366–3.668 | 0.001 | 1.744 | 1.038–2.928 | 0.036 |
Slug expression | ||||||
Low | 1.00 (ref.) | 1.00 (ref.) | ||||
High | 1.785 | 1.133–2.813 | 0.012 | 0.727 | 0.410–1.288 | 0.274 |
ZEB1 expression | ||||||
Low | 1.00 (ref.) | 1.00 (ref.) | ||||
High | 1.181 | 0.765–1.822 | 0.128 | 1.239 | 0.749–2.051 | 0.404 |
Twist expression | ||||||
Low | 1.00 (ref.) | 1.00 (ref.) | ||||
High | 2.131 | 1.341–3.386 | 0.001 | 0.926 | 0.434–1.980 | 0.844 |
Vimentin expression | ||||||
Low | 1.00 (ref.) | 1.00 (ref.) | ||||
High | 2.226 | 1.387–3.573 | 0.001 | 1.467 | 0.828–2.599 | 0.189 |
Survivin expression | ||||||
Low | 1.00 (ref.) | 1.00 (ref.) | ||||
High | 1.791 | 1.135–2.827 | 0.012 | 1.348 | 0.737–2.465 | 0.332 |
E-cadherin expression | ||||||
Low | 1.00 (ref.) | 1.00 (ref.) | ||||
High | 2.612 | 1.583–4.309 | <0.001 | 1.738 | 1.008–2.998 | 0.047 |
AD, adenocarcinoma; ASC, adenosquamous cell carcinoma; CI, confidence interval; FIGO, International Federation of Gynecology and Obstetrics; HR, hazard ratio; SCC, squamous cell carcinoma. Bold font indicates p-values < 0.05.